移至主內容

Can simple hysterectomy safely replace radical hysterectomy for women with early-stage cervical cancer?

亦提供以下語言

Key messages

  • Simple hysterectomy may result in little to no difference in the number of deaths from any cause, life expectancy after treatment, deaths from cancer, cancer-free period after treatment, or the rate at which cancer returned compared to radical hysterectomy.

  • Simple hysterectomy likely reduces unwanted adverse effects from surgery.

  • Women undergoing simple hysterectomy may have better sexual health and overall well-being compared to those who undergo radical hysterectomy.

What is a surgical treatment of early-stage cervical cancer?

Radical hysterectomy is generally considered a standard surgical treatment for women with early-stage cervical cancer. Radical hysterectomy involves the removal of the womb, cervix (neck of the womb), surrounding tissues (parametrial tissue), and part of the vagina. Unwanted side effects from surgery include injury to the bowel, bladder, blood vessels, ureters (the tubes that transport urine from the kidneys to the bladder), and nerves, resulting in difficulty in bladder emptying and false track (fistula) formation.

What did we want to find out?

Since small cervical cancers are unlikely to spread to nearby tissues, a simple hysterectomy—which removes only the uterus and cervix—could be a suitable choice instead of a radical hysterectomy. Compared with radical surgery, a simple hysterectomy avoids unnecessary removal of surrounding tissues, which may avoid the risk of damage to nerves and the ureters. However, as simple hysterectomy removes a smaller margin of normal tissue around the cervix, there may be a higher risk that the cancer is not completely removed. Therefore, we want to find out if a simple hysterectomy is a safe and effective alternative compared to a radical hysterectomy for women with small cervical cancers.

What did we do?

We looked for studies that compared the health outcomes of women who were randomly assigned to have either a simple hysterectomy or a radical hysterectomy, both with the removal of pelvic lymph nodes. We focused on women with cervical cancer in stages IA2 to IB1. Stage IA2 means the cancer has grown 3 mm to 5 mm into the cervix, and stage IB1 means the cancer has grown more than 5 mm into the cervix but is no larger than 2 cm and has not spread beyond it.

What did we find?

We found two studies including 740 women. One small study (40 women) was conducted in Brazil. The larger study, involving 700 women, included centres in Western Europe, South Korea, and Canada. In this larger trial, three-quarters of the included women were white.

The results showed that simple hysterectomy might not change the number of deaths from any cause, life expectancy after treatment, cancer-free period after treatment, or the rate at which cancer returns compared to radical hysterectomy. In addition, simple hysterectomy might not increase deaths from cancer when compared to radical hysterectomy, but the evidence is very uncertain. Simple hysterectomy likely resulted in fewer unwanted side effects from surgery.

Women who underwent simple hysterectomy appeared to have better sexual health and overall well-being. Also, simple hysterectomy was less expensive than radical hysterectomy.

What are the limitations of the evidence?

We are not very confident in the evidence. The two included studies only gathered information over a short period of time about how long it takes for someone to die or for cancer to come back. Also, not many non-white women or women from low-resource settings were included. The studies did not control for differences in surgical methods (open surgery and minimal access ‘keyhole’ surgery), which might affect rates of cancer coming back and side effects of surgery. Currently, we do not know the best type and route of surgery for women with cervical cancer who have small tumours and limited invasion (shallow spreading into the deeper layers of the cervix), and more studies are needed to find out.

How up-to-date is this evidence?

The evidence is current to March 2025.

目的

To determine the benefits and harms of simple hysterectomy with pelvic lymphadenectomy versus radical hysterectomy with pelvic lymphadenectomy for women with stage IA2-IB1 cervical cancer.

搜尋策略

We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid), Embase (Ovid), Web of Science Core Collection, PubMed, and two trial registry databases, along with reference checking and citation searching. The last search date was 19 March 2025.

作者結論

Simple hysterectomy may be a viable option for carefully selected women with early-stage cervical cancer, as it may result in little to no differences in survival and cancer recurrence rates compared to radical hysterectomy. Additionally, there were likely fewer perioperative adverse events and there may be better short-term QoL and sexual function in women undergoing simple hysterectomy. The included studies did not directly compare the effect of the route of surgery (open versus minimal access). This review has a limited representation of non-white women and women from low-resource settings.

Funding

No specific funding was received for this review.

Registration

Cochrane protocol (2016) DOI: 10.1002/14651858.CD012335.
PROSPERO 2016 CRD42016047631. Available from: crd.york.ac.uk/PROSPERO/view/CRD42016047631

引用文獻
Kietpeerakool C, Rattanakanokchai S, Shawky M, Morrison J. Simple hysterectomy with pelvic lymphadenectomy versus radical hysterectomy with pelvic lymphadenectomy for women with stage IA2-IB1 cervical cancer. Cochrane Database of Systematic Reviews 2025, Issue 10. Art. No.: CD012335. DOI: 10.1002/14651858.CD012335.pub2.

我們對Cookie的使用

我們使用必要的 cookie 使我們的網站正常運作。我們還希望設置可選擇分析的 cookie,以幫助我們進行改進網站。除非您啟用它們,否則我們不會設置可選擇的 cookie。使用此工具將在您的設備上設置 cookie,以記住您的偏好。您隨時可以隨時通過點擊每個頁面下方的「Cookies 設置」連結來更改 Cookie 偏好。
有關我們使用 cookie 的更多詳細資訊,請參閱我們的 cookie 頁面

接受所有
配置